In the training phase, after stratifying by stage, they found that RAN /rs14035 and miR-373/rs12983273 showed a highly significant association with recurrence-free survival in stage II patients, whereas miR-608/rs4919510, GEMIN3 /rs197412, XPO5 /rs11077, AGO2 /rs4961280, GEMIN4 /rs2740348, GEMIN3 /rs197388, and GEMIN4 /rs7813 did so in stage III patients.
2
—
—
The sentences
The group with low miR-148a-3p expression showed a trend toward a worse progression-free survival (PFS) and significantly worse OS in stage IV patients.